Macular degeneration trials in Israel

In Israel 9 Also abroad 220

9 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Where
Jerusalem, Tel Aviv
Age
55 years to 64 years
People
110 worldwide
Run by
Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00
Phase 3Taking people
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Rehovot, Tel Aviv, Tsrifin
Age
50 years and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00
Phase 3Taking people
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Rehovot, Tel Aviv
Age
50 years and over
People
1,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00
Phase 3Active, not recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Haifa, Holon, Jerusalem, Ramat Gan, Rehovot, Tel Aviv
Age
50 years and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
Phase 2Taking people
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Where
Jerusalem, Tel Aviv
Age
50 years and over
People
60 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT05626114
Phase 2/3Taking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Where
Ashkelon, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Rehovot, Tsrifin
Age
50 years and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07440225
Phase 1/2Taking people
A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Tel Aviv
Age
55 years to 80 years
People
62 worldwide
Run by
Kriya Therapeutics, Inc.
See details and how to joinNCT06765980
No phaseEnrolling by invitation
Long-Term Follow Up of VOY-101 Non-nAMD Extension Study
Where
Tel Aviv
Age
50 years and over
People
88 worldwide
Run by
Perceive Biotherapeutics, Inc.
See details and how to joinNCT07660640
No phaseTaking people
Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Where
Jerusalem
Age
18 years and over
People
120
Run by
Hadassah Medical Organization
See details and how to joinNCT00874783